The coronavirus vaccine could be approved on Thanksgiving, Monsieur Slavey, the chief scientist leading the Trump administration’s coronavirus vaccine initiative, told Fox News on Tuesday.
In a rare interview with History, Slavey said he expects two of the vaccines currently registered in phase 3 clinical trials to reach a certain criterion by “the end of this month and next month” before they can apply for emergency use by Food and Drug Administration.
“Thanksgiving, shortly before or shortly after, will be my best assessment,” Slavey told host Martha McAlum, “but it̵
Slavey, who is the driving force behind Operation Warp Speed, a multi-agency collaboration led by the Ministry of Health and Social Services, explained the unprecedented pace of development, reassuring skeptics who questioned the safety and effectiveness of the vaccine.
CLICK FOR FULL CORONAVIRUS COVERAGE
“It was extremely fast for a number of reasons,” he said. “It’s one thing that we’ve learned a lot in the last 10, 15 years about what is called platform technology, which is the basis of a number of vaccines, where 80%, 90% of the way you make a vaccine is already predefined.
“So we used this platform technology that we knew could be fast, could be safe, could be produced on a scale … and that was one of the reasons we were going very fast.”
More than 7.8 million have been infected with COVID-19 in the United States and at least 215,861 have died.
“The second reason is … we prepared, we took financial risk, we didn’t take any safety risks and we managed to prepare for the Phase 1, Phase 2, Phase 3 test … so we cut all the blanks, and less 10 months after the discovery of this virus, we have six programs in clinics, four of which are in phase three trials, “added Siaoui.
Despite his optimistic predictions, Slavey is “extremely concerned about how politicized this situation around the vaccine is and how people are reacting to it.”
“We will be completely transparent, people will understand exactly the effect of the vaccine, their safety and benefits,” he said, “and I hope people realize that the only way to really allow us to move away and control this pandemic would be through mass vaccination. “
Slavey’s comments came after pharmaceutical giant Johnson & Johnson announced it had halted its pause in the final phase of the COVID-19 vaccine after a participant was reported to have “unexplained disease,” something he called “not uncommon.” “.
JOHNSON & JOHNSON PAUSE CORONAVIRUS VACCINE SAMPLE
“There are almost always serious events in all clinical trials,” he explained. “Of course, they don’t happen in the spotlight while the whole country is looking at them. The key here is that each vaccine monitors its safety very, very carefully and the trials are delayed. [to] try to find out what’s going on. If the vaccine is considered to be still safe and may progress because the event is not actually related to vaccination, it will continue. If considered a problem, the tests will be stopped. “
Asked at one point if anyone could be infected twice with coronavirus, Slavey said, “exceptions always exist.”
Click here to get the FOX NEWS app
“But,” he added, “the exception is not the rule here. The rule is that most people will be protected after exposure or vaccination.”